174 related articles for article (PubMed ID: 25665484)
1. Anti-angiogenic activities of snake venom CRISP isolated from Echis carinatus sochureki.
Lecht S; Chiaverelli RA; Gerstenhaber J; Calvete JJ; Lazarovici P; Casewell NR; Harrison R; Lelkes PI; Marcinkiewicz C
Biochim Biophys Acta; 2015 Jun; 1850(6):1169-79. PubMed ID: 25665484
[TBL] [Abstract][Full Text] [Related]
2. Vixapatin (VP12), a c-type lectin-protein from Vipera xantina palestinae venom: characterization as a novel anti-angiogenic compound.
Momic T; Cohen G; Reich R; Arlinghaus FT; Eble JA; Marcinkiewicz C; Lazarovici P
Toxins (Basel); 2012 Oct; 4(10):862-77. PubMed ID: 23162702
[TBL] [Abstract][Full Text] [Related]
3. Lebectin, a Macrovipera lebetina venom-derived C-type lectin, inhibits angiogenesis both in vitro and in vivo.
Pilorget A; Conesa M; Sarray S; Michaud-Levesque J; Daoud S; Kim KS; Demeule M; Marvaldi J; El Ayeb M; Marrakchi N; Béliveau R; Luis J
J Cell Physiol; 2007 May; 211(2):307-15. PubMed ID: 17323383
[TBL] [Abstract][Full Text] [Related]
4. Isolation of an Anti-Tumour Disintegrin: Dabmaurin-1, a Peptide Lebein-1-Like, from
Chalier F; Mugnier L; Tarbe M; Aboudou S; Villard C; Kovacic H; Gigmes D; Mansuelle P; de Pomyers H; Luis J; Mabrouk K
Toxins (Basel); 2020 Feb; 12(2):. PubMed ID: 32033352
[TBL] [Abstract][Full Text] [Related]
5. PIVL, a snake venom Kunitz-type serine protease inhibitor, inhibits in vitro and in vivo angiogenesis.
Morjen M; Honoré S; Bazaa A; Abdelkafi-Koubaa Z; Ellafi A; Mabrouk K; Kovacic H; El Ayeb M; Marrakchi N; Luis J
Microvasc Res; 2014 Sep; 95():149-56. PubMed ID: 25173589
[TBL] [Abstract][Full Text] [Related]
6. Vascular disrupting activity of combretastatin analogues.
Porcù E; Salvador A; Primac I; Mitola S; Ronca R; Ravelli C; Bortolozzi R; Vedaldi D; Romagnoli R; Basso G; Viola G
Vascul Pharmacol; 2016 Aug; 83():78-89. PubMed ID: 27235861
[TBL] [Abstract][Full Text] [Related]
7. Anti-angiogenic quassinoid-rich fraction from Eurycoma longifolia modulates endothelial cell function.
Al-Salahi OS; Kit-Lam C; Majid AM; Al-Suede FS; Mohammed Saghir SA; Abdullah WZ; Ahamed MB; Yusoff NM
Microvasc Res; 2013 Nov; 90():30-9. PubMed ID: 23899415
[TBL] [Abstract][Full Text] [Related]
8. Importance of interaction between nerve growth factor and α9β1 integrin in glial tumor angiogenesis.
Walsh EM; Kim R; Del Valle L; Weaver M; Sheffield J; Lazarovici P; Marcinkiewicz C
Neuro Oncol; 2012 Jul; 14(7):890-901. PubMed ID: 22611032
[TBL] [Abstract][Full Text] [Related]
9. Suppression of VEGF-induced angiogenesis and tumor growth by Eugenia jambolana, Musa paradisiaca, and Coccinia indica extracts.
M HR; Ghosh D; Banerjee R; Salimath BP
Pharm Biol; 2017 Dec; 55(1):1489-1499. PubMed ID: 28367666
[TBL] [Abstract][Full Text] [Related]
10. Norcantharidin: a potential antiangiogenic agent for gallbladder cancers in vitro and in vivo.
Zhang JT; Fan YZ; Chen CQ; Zhao ZM; Sun W
Int J Oncol; 2012 May; 40(5):1501-14. PubMed ID: 22200632
[TBL] [Abstract][Full Text] [Related]
11. A horsefly saliva antigen 5-like protein containing RTS motif is an angiogenesis inhibitor.
Ma D; Gao L; An S; Song Y; Wu J; Xu X; Lai R
Toxicon; 2010 Jan; 55(1):45-51. PubMed ID: 19635491
[TBL] [Abstract][Full Text] [Related]
12. Eriocalyxin B, a natural diterpenoid, inhibited VEGF-induced angiogenesis and diminished angiogenesis-dependent breast tumor growth by suppressing VEGFR-2 signaling.
Zhou X; Yue GG; Liu M; Zuo Z; Lee JK; Li M; Tsui SK; Fung KP; Sun H; Pu J; Lau CB
Oncotarget; 2016 Dec; 7(50):82820-82835. PubMed ID: 27756875
[TBL] [Abstract][Full Text] [Related]
13. CC5 and CC8, two homologous disintegrins from Cerastes cerastes venom, inhibit in vitro and ex vivo angiogenesis.
Ben-Mabrouk H; Zouari-Kessentini R; Montassar F; Koubaa ZA; Messaadi E; Guillonneau X; ElAyeb M; Srairi-Abid N; Luis J; Micheau O; Marrakchi N
Int J Biol Macromol; 2016 May; 86():670-80. PubMed ID: 26853827
[TBL] [Abstract][Full Text] [Related]
14. Anti-angiogenic and vascular disrupting effects of C9, a new microtubule-depolymerizing agent.
Ren X; Dai M; Lin LP; Li PK; Ding J
Br J Pharmacol; 2009 Apr; 156(8):1228-38. PubMed ID: 19302593
[TBL] [Abstract][Full Text] [Related]
15. Cryptotanshinone inhibits VEGF-induced angiogenesis by targeting the VEGFR2 signaling pathway.
Xu X; Wu L; Zhou X; Zhou N; Zhuang Q; Yang J; Dai J; Wang H; Chen S; Mao W
Microvasc Res; 2017 May; 111():25-31. PubMed ID: 28040437
[TBL] [Abstract][Full Text] [Related]
16. Anti-angiogenic effects of a mutant endostatin: a new prospect for treating retinal and choroidal neovascularization.
Bai Y; Zhao M; Zhang C; Li S; Qi Y; Wang B; Huang L; Li X
PLoS One; 2014; 9(11):e112448. PubMed ID: 25380141
[TBL] [Abstract][Full Text] [Related]
17. Nelumbo nucifera Gaertn leaves extract inhibits the angiogenesis and metastasis of breast cancer cells by downregulation connective tissue growth factor (CTGF) mediated PI3K/AKT/ERK signaling.
Chang CH; Ou TT; Yang MY; Huang CC; Wang CJ
J Ethnopharmacol; 2016 Jul; 188():111-22. PubMed ID: 27178635
[TBL] [Abstract][Full Text] [Related]
18. Formononetin, a novel FGFR2 inhibitor, potently inhibits angiogenesis and tumor growth in preclinical models.
Wu XY; Xu H; Wu ZF; Chen C; Liu JY; Wu GN; Yao XQ; Liu FK; Li G; Shen L
Oncotarget; 2015 Dec; 6(42):44563-78. PubMed ID: 26575424
[TBL] [Abstract][Full Text] [Related]
19. Plumbagin inhibits tumour angiogenesis and tumour growth through the Ras signalling pathway following activation of the VEGF receptor-2.
Lai L; Liu J; Zhai D; Lin Q; He L; Dong Y; Zhang J; Lu B; Chen Y; Yi Z; Liu M
Br J Pharmacol; 2012 Feb; 165(4b):1084-96. PubMed ID: 21658027
[TBL] [Abstract][Full Text] [Related]
20. Anti-angiogenic and anti-inflammatory properties of kahweol, a coffee diterpene.
Cárdenas C; Quesada AR; Medina MA
PLoS One; 2011; 6(8):e23407. PubMed ID: 21858104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]